Enovis (ENOV) Cash from Investing Activities (2010 - 2026)
Enovis' (ENOV) quarterly Cash from Investing Activities came in at -$45.0 million in Q3 2026, up 9.62% year-over-year from -$41.1 million in Q3 2025, and up 15.23% quarter-over-quarter from -$53.1 million in Q2 2026.
Analysis
Enovis (ENOV) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Cash from Investing Activities for 17 consecutive years, with -$45.0 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Cash from Investing Activities rose 9.62% year-over-year to -$45.0 million in Q3 2026; TTM through Jul 2026 was -$167.2 million, a 26.24% increase from a year earlier, with the FY2025 full-year figure at -$179.4 million, up 81.23% from the prior year.
- Cash from Investing Activities was -$45.0 million for Q3 2026 at Enovis, up from -$53.1 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$13.0 million in Q4 2025 and troughed at -$797.8 million in Q1 2024.
- A 5-year average of -$91.8 million and a median of -$51.4 million in 2025 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities slumped 2220.32% in 2024 and surged 92.41% in 2025, its largest moves.
- Over 5 years, Cash from Investing Activities stood at -$37.1 million in 2022, then slumped by 60.14% to -$59.4 million in 2023, then advanced by 2.51% to -$57.9 million in 2024, then surged by 77.56% to -$13.0 million in 2025, then sank by 246.48% to -$45.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$45.0 million (Q3 2026), -$53.1 million (Q2 2026), and -$13.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | -45.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | -45.01 Mn |
| Apr 3, 2026 | -53.10 Mn |
| Dec 31, 2025 | -12.99 Mn |
| Oct 3, 2025 | -56.06 Mn |
| Jul 4, 2025 | -49.80 Mn |
| Apr 4, 2025 | -60.52 Mn |
| Dec 31, 2024 | -57.88 Mn |
| Sep 27, 2024 | -58.42 Mn |
| Jun 28, 2024 | -41.33 Mn |
| Mar 29, 2024 | -797.84 Mn |
| Dec 31, 2023 | -59.37 Mn |
| Sep 29, 2023 | -17.11 Mn |
| Jun 30, 2023 | -131.60 Mn |
| Mar 31, 2023 | -34.39 Mn |
| Dec 31, 2022 | -37.08 Mn |
| Sep 30, 2022 | -59.14 Mn |
| Jul 1, 2022 | -45.01 Mn |
| Apr 1, 2022 | -35.17 Mn |
| Dec 31, 2021 | -26.83 Mn |
| Oct 1, 2021 | -21.55 Mn |